Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Correction to Vertex's FDA Warning Story

12/19/2012| 05:22pm US/Eastern
Recommend:
0

"Vertex's Hepatitis C Drug Receives Another Blow With FDA Warning" published at 4:39 p.m. ET incorrectly said the new warning instructs patients to discontinue their use of the drug if a severe rash occurs. The warning to discontinue use existed on the previous label, but the new warning adds that severe rashes have resulted in deaths.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
Partner Area
React to this article
 
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS INCORPORATED: Vertex Calls for Redemption of $400 Millio..
05/09 VERTEX PHARMACEUTICALS INCORPORATED: Vertex Pharmaceuticals Announces Webcasts ..
05/01DJU.S. HOT STOCK FUTURES: Hot stocks to watch
05/01DJU.S. HOT STOCK FUTURES: Hot stocks to watch -2-
05/01DJU.S. HOT STOCK FUTURES: Hot stocks to watch
04/30DJVertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down
04/30DJVertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down
04/30 VERTEX PHARMACEUTICALS INCORPORATED: Vertex Reports First Quarter 2013 Financia..
04/24DJFDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
04/24 VERTEX PHARMACEUTICALS INCORPORATED: Vertex Announces New Data that Showed High..
Advertisement
Chart
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.